Compare CVS Health Corp (CVS) vs Liberty Global Ltd Class C (LBTYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Liberty Global Ltd Class C — how do they compare? CVS Health Corp trades at $86.82 (market cap $112.49B), while Liberty Global Ltd Class C trades at $8.79 (market cap $3.12B). The key difference: CVS Health Corp is far larger — about 36.1× Liberty Global Ltd Class C's market cap, and CVS Health Corp pays a 3.02% dividend while Liberty Global Ltd Class C pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Liberty Global Ltd Class C for 21 Days on average.
| CVS | LBTYK | |
|---|---|---|
Market Cap | $112.49B | $3.12B |
Volume | 8,467,392 | 1,096,842 |
Sector | Health | Media |
52-Week High | $110.60 | $12.67 |
52-Week Low | $70.08 | $8.75 |
Typical Hold Time | 83 Days | 21 Days |
Enterprise Value | $174.83B | $9.78B |
Dividend Yield | 3.02% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.
The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.
LBTYK is trading at $8.92, down 0.28% on the day, and is near its 52-week low. The stock shows a bearish technical trend with mixed earnings, including a recent Q1 2026 beat but a Q2 2026 miss. Financially, it has a negative net income margin of -62.14% for 2026, though revenue remains stable at $4.9B. Recent news highlights strategic moves like the Ziggo Group spin-off planned for 2027 and an AI partnership to enhance customer experiences.
The outlook is cautious; while analyst consensus is bullish with a $12.67 price target, high losses and bearish technicals pose risks. Upside potential hinges on successful asset monetization and the Ziggo listing, but investors face volatility from ongoing profitability challenges and market sentiment shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Liberty Global Ltd Class C
Liberty Global is a world leader in converged broadband, video, and mobile communications. It operates large-scale fiber and 5G networks across Europe, providing essential digital services to millions of customers.
Read more on LBTYK →
